Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases

OBJECTIVES: The efficacy of a partial agonist for the dopamine D(2) receptor, aripiprazole, for catatonia in schizophrenia has been reported. METHODS: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe catatonic symptoms improved. RESULTS: In the fi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:SAGE Open Med Case Rep
Hoofdauteurs: Muneoka, Katsumasa, Kanahara, Nobuhisa, Kimura, Shou
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2017
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5315413/
https://ncbi.nlm.nih.gov/pubmed/28255444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17692936
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items